The US faces a critical deadline in January 2026 to prove it has stopped measles

December 16, 2025 No Comments

All living organisms adapt in order to survive, and bacteria are no exception. Over many

December 16, 2025 No Comments

We are continuing our new series, Media Day, where we spotlight individual medical institutions and their

December 15, 2025 No Comments

This morning, Gilead Sciences announced positive topline results from its phase 3 ARTISTRY-2 trial evaluating

December 15, 2025 No Comments

For many people living with long COVID, ongoing issues such as breathlessness, fatigue and brain

December 15, 2025 No Comments

As antimicrobial resistance continues to erode the effectiveness of standard gonorrhea therapies, the clinical community

December 14, 2025 No Comments

Children who returned to in-person school during the COVID-19 pandemic were much less likely to

December 13, 2025 No Comments

With support from artificial intelligence, an international group of scientists has taken an important early

December 13, 2025 No Comments

Today, the FDA approved Innoviva Specialty Therapeutics’ zoliflodacin (Nuzolvence), a first-in-class, single-dose oral medication for

December 12, 2025 No Comments

Schedule an Appointment

Quick Links